biostudies-literatureUnknown42(2)Isnardi CAPfizerILARElea PhenixAbbVie<h4>Background/objective</h4>This study aims to describe the course and to identify poor prognostic factors of SARS-CoV-2 infection in patients with rheumatic diseases.<h4>Methods</h4>Patients ≥ 18 years of age, with a rheumatic disease, who had confirmed SARS-CoV-2 infection were consecutively included by major rheumatology centers from Argentina, in the national, observational SAR-COVID registry between August 13, 2020 and July 31, 2021. Hospitalization, oxygen requirement, and death were considered poor COVID-19 outcomes.<h4>Results</h4>A total of 1915 patients were included. The most frequent rheumatic diseases were rheumatoid arthritis (42%) and systemic lupus erythematosus (16%). Comorbidities were reported in half of them (48%). Symptoms were reported by 95% of the patients, 28% werClinical rheumatology563-578https://www.ebi.ac.uk/biostudies/studies/S-EPMC9535223biostudies-literatureSociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.PMC9535223Amitrano CLazaro MASerrano RAsnal CPisoni CNGomez CCarrillo IGamba MJBedran ZNPerez Rodriguez MSBorgia MVYohena VGuinsburg MMunoz LMde Los Angeles Severina MPaniego FMGraf CMaldonado FNAlonso CGQuaglia MIRaiti LCarlevaris LMartin MLGuzzanti FGallo RAlle GConti SPetkovic IHaye Salinas MJDieguez CPons-Estel BACosatti MRisueno FBaez RMS. A. R.–COVID Registry InvestigatorsBuschiazzo EGalvez Elkin MSDe la Vega MVerna GBellomio VTesti ATralice ERPicco ECusa MACogo KCastro Coello VPetruzzeli SCatalan Pellet SQuagliato NJTanten RFigueroa RMSeverina MGallino Yanzi JRojas Tessel IRCasalla LCordoba MCPerez Alamino RRodriguez Gil GFBanos ACalvo MERebak JEGonzalez Lucero LMartire MVAlba APereira DBetancur GVMoyano SAlba PDe la Vega MCCastro Coello VVDe La Vega Fernandez SSRoldan BMLandi MPera MCastrillon DMVillafane Torres JAAguero SERoberts KPaniego RBarbich TD Angelo Exeni MEBerbotto GIsnardi CADiaz MPReyes Torres AAPisoni CViola MMorales NGerman NFMauri MEMerce ALRetamozo CMareco JMWerner MLPons-Estel GFinucci Curi PRomeo CGerman NVillafane JGarcia MVara ABGSchmid MMMaldonado Ficco HTamborenea MNVelozo ENieto RESavio VGMatellan CNovatti EGomez CRRCucchiaro NLTomas JLPaula AKisluk BMamani Ortega MLSoares de Souza STissera YMedina MABertoli APorta SRodriguez FAeschlimann CJuarez VPons-Estel GJPendon GZelaya MDNieto RMaid PGobbi CGoizueta COrnella SVivero FScafati JSubils GExeni IETakashima Lde Los Angeles Correa MCosentino VAlonso MDCroce MMCogo AKLloves Schenone NMAbadie FVelasco Zamora JLMolina Merino HAVasquez DLBedoya MESoriano ERIbanez Zurlo LCastanos Menescardi MSSaurit VQuintana RMaldini CGuaglionone DGomez GLedesma ACQuinteros APineda SIHerscovich NAAlbiero JAMorbiducci JSfalseSociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.<h4>Background/objective</h4>This study aims to describe the course and to identify poor prognostic factors of SARS-CoV-2 infection in patients with rheumatic diseases.<h4>Methods</h4>Patients ≥ 18 years of age, with a rheumatic disease, who had confirmed SARS-CoV-2 infection were consecutively included by major rheumatology centers from Argentina, in the national, observational SAR-COVID registry between August 13, 2020 and July 31, 2021. Hospitalization, oxygen requirement, and death were considered poor COVID-19 outcomes.<h4>Results</h4>A total of 1915 patients were included. The most frequent rheumatic diseases were rheumatoid arthritis (42%) and systemic lupus erythematosus (16%). Comorbidities were reported in half of them (48%). Symptoms were reported by 95% of the patients, 28% wer2023-01-01T00:00:00Z2023 Feb2025-04-22T21:51:41.954Z2025-02-19T01:27:46.738ZS-EPMC95352233620112410.1007/s10067-022-06393-8